NTM-AS1
gene geneOn this page
Also known as FLJ45436
Summary
NTM-AS1 (NTM antisense RNA 1, HGNC:32293) is a long non-coding RNA gene on chromosome 11q25.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:32293 |
| Approved symbol | NTM-AS1 |
| Name | NTM antisense RNA 1 |
| Location | 11q25 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Aliases | FLJ45436 |
| Ensembl gene | ENSG00000224795 |
| Ensembl biotype | lncRNA |
| Entrez | 101929637 |
| RNAcentral | URS00007E48E9 — lncRNA, 678 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 5 — 5 lncRNA
ENST00000416725, ENST00000663555, ENST00000775197, ENST00000775198, ENST00000775199
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000416725 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00004141759 | 131663166 | 131663635 |
| ENSE00004141760 | 131658310 | 131662415 |
Expression profiles
Bgee: expression breadth broad, 63 present calls, max score 84.97.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 1.1675 / max 108.5483, expressed in 88 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 123183 | 1.0410 | 85 |
| 123184 | 0.0745 | 49 |
| 123182 | 0.0520 | 37 |
Top tissues by expression
63 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| corpus callosum | UBERON:0002336 | 84.97 | gold quality |
| putamen | UBERON:0001874 | 73.21 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 72.19 | silver quality |
| substantia nigra | UBERON:0002038 | 71.87 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 71.69 | gold quality |
| caudate nucleus | UBERON:0001873 | 70.52 | gold quality |
| amygdala | UBERON:0001876 | 69.72 | gold quality |
| temporal lobe | UBERON:0001871 | 69.69 | gold quality |
| Ammon’s horn | UBERON:0001954 | 69.62 | gold quality |
| colonic epithelium | UBERON:0000397 | 67.98 | silver quality |
| nucleus accumbens | UBERON:0001882 | 65.69 | gold quality |
| primary visual cortex | UBERON:0002436 | 65.55 | gold quality |
| prefrontal cortex | UBERON:0000451 | 65.36 | gold quality |
| brain | UBERON:0000955 | 64.45 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 64.20 | gold quality |
| frontal cortex | UBERON:0001870 | 64.14 | gold quality |
| cerebral cortex | UBERON:0000956 | 63.94 | gold quality |
| hypothalamus | UBERON:0001898 | 62.74 | gold quality |
| right frontal lobe | UBERON:0002810 | 62.31 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 62.18 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 60.56 | gold quality |
| multicellular organism | UBERON:0000468 | 60.36 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 59.96 | gold quality |
| sural nerve | UBERON:0015488 | 55.27 | silver quality |
| blood | UBERON:0000178 | 55.05 | gold quality |
| small intestine | UBERON:0002108 | 53.83 | silver quality |
| monocyte | CL:0000576 | 51.30 | silver quality |
| saliva-secreting gland | UBERON:0001044 | 49.85 | gold quality |
| myometrium | UBERON:0001296 | 48.12 | silver quality |
| cerebellum | UBERON:0002037 | 47.80 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.40 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.